Now offering convenient delivery options. Learn more
Now offering convenient delivery options. Learn more
December 07, 2020 1 min read
NSW could significantly increase technological innovation and new product development by creating beta-testing sites within NSW for university researchers.
Stoic Venture Capital Partner Dr Geoff Waring said technology innovation lifts employment while improving competitiveness of local companies at a global level.
“Creating a policy for beta-testing sites in NSW for university researchers would attract researchers, entrepreneurs, start-up companies, venture capital and multinationals to NSW,” Dr Waring said.
“It could also help to develop links between university research and industry as well as lead to the creation of new technology start-ups from the intellectual property developed at local universities.”
Dr Waring said NSW’s current procurement innovation stream for small and medium sized companies whereby contracts of up to $1 million may be awarded following successful proof of concept trial, does not currently meet the needs of university researchers who are at a very early level of development.
Many of NSW’s most difficult problems are beyond the technology capability of existing suppliers, so need unproven technology development, he said.
“These difficult problems include ecological conservation, the effects of climate change and pandemics. University researchers have a parallel problem proving their technology that works in the lab also works and is safe in use. Venture capital investors want to see a proof of concept before they invest. All these parties gain from a small-scale beta test.”
January 28, 2022 2 min read
November 22, 2021 2 min read
October 25, 2021 1 min read
US and Australia-based researchers have discovered a cheap new way to capture and convert CO2 emissions using liquid gallium.
As the largest Significant Investor Visa (SIV) programme investment manager, we have over 400 HNW individuals/family offices investors from Australia, Singapore, Malaysia, Hongkong SAR and China. Learn why we are experts in this area and how we invest.
Subscribe to our monthly newsletter and never miss out on the very latest!